Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo

Kidney International
Christian HugoR J Johnson

Abstract

Thrombospondin 1 has been shown to be linked to PDGF-mediated mesangial cell proliferation and migration in vitro, but little is known regarding its expression or regulation in glomerular disease. Experimental mesangial proliferative nephritis was induced in rats by injection of anti-Thy1 antibody. Mesangial cell proliferation was associated with de novo expression of thrombospondin 1 mRNA (detected by Northern blot and in situ hybridization) and protein (by Western blot and immunostaining). Although some thrombospondin 1 was expressed by platelets and macrophages, double labeling showed that most thrombospondin 1 mRNA and protein were expressed by proliferating alpha-actin-positive mesangial cells. Thrombospondin 1 expression in anti-Thy1 nephritis was complement-dependent and could be reduced by treatment with anti-PDGF or anti-bFGF antibodies. Thrombospondin 1 could also be induced in normal rats by infusion of PDGF and in rats which were primed with low dose anti-Thy1 antibody by infusion of PDGF of bFGF. Thus, this study demonstrates that proliferating mesangial cells express thrombospondin 1 de novo in disease and that thrombospondin 1 expression in vivo is regulated by PDGF and bFGF.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
May 1, 1992·Hypertension·R J JohnsonS M Schwartz
Apr 1, 1992·Journal of the American Society of Nephrology : JASN·R J JohnsonC E Alpers
Apr 1, 1991·The Journal of Clinical Investigation·G P Tuszynski, M A Kowalska
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·V Lindner, M A Reidy
Dec 1, 1990·The Journal of Cell Biology·P J MansfieldS J Suchard
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B J SilverH E Abboud
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J N WilcoxD Gordon
Aug 1, 1988·European Journal of Biochemistry·P ClezardinJ L McGregor
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R A MajackP Bornstein
Mar 1, 1987·The Journal of Clinical Investigation·R L Silverstein, R L Nachman
Jan 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·N L BaenzigerP W Majerus
Jan 1, 1994·Methods in Enzymology·P Bornstein, E H Sage
Aug 1, 1993·Journal of the American Society of Nephrology : JASN·R J JohnsonC E Alpers

❮ Previous
Next ❯

Citations

Oct 16, 2008·Histochemistry and Cell Biology·Andreas GoldwichErnst R Tamm
Mar 10, 2000·Cytokine & Growth Factor Reviews·J E Murphy-Ullrich, M Poczatek
Aug 21, 2013·Cellular & Molecular Immunology·Yanzhang LiShuxia Wang
Oct 9, 2003·Kidney International·Ji Hoon KimHyun Soon Lee
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christian Hugo
Jul 4, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bernd HohensteinChristian Hugo
Jan 14, 2004·Kidney International·Christoph DanielChristian Hugo
Feb 19, 2010·American Journal of Physiology. Cell Physiology·Shuxia WangJoanne E Murphy-Ullrich
Mar 20, 2010·American Journal of Physiology. Renal Physiology·Bernd HohensteinMichael S Goligorsky
Aug 15, 1997·The Journal of Clinical Investigation·C HugoR J Johnson
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Minh D Tran, Joseph T Neary
Nov 30, 2006·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·H E GruberE N Hanley
Jul 16, 2004·Kidney International·Takahiko NakagawaRichard J Johnson
May 1, 1997·Kidney International·P Pintavorn, B J Ballermann
Apr 6, 2001·The American Journal of Pathology·M YanagitaT Kita
Jul 22, 1999·Experimental Cell Research·G Serini, G Gabbiani
Mar 20, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J L BarnesV L Barnes
Mar 21, 1998·Toxicologic Pathology·J W Verlander
Feb 13, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Christoph DanielChristian Hugo
Jan 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·R RiessenJ Lawler
Jan 12, 2007·Journal of the American Society of Nephrology : JASN·Bernd HohensteinChristian P M Hugo
Mar 21, 2019·American Journal of Physiology. Renal Physiology·Erika GuiseAlejandro R Chade
Apr 27, 2012·Physiological Reviews·Nikolaos G Frangogiannis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.